Literature DB >> 11316978

Nephrogenic adenoma of the urinary bladder: our experience and review of the literature.

A B Porcaro1, A D'Amico, V Ficarra, M Balzarro, R Righetti, G Martignoni, S Cavalleri, G Malossini.   

Abstract

OBJECTIVE: To assess our experience in the treatment and clinical outcome of bladder nephrogenic adenoma (NA) updating and reviewing the literature concerning this issue. PATIENTS AND METHODS: From September 1976 to June 1999, bladder NA was diagnosed in 8 patients: 6 men and 2 women with a 3:1 male ratio, aged 26-80 (mean 58.3) years. Follow-up ranged from 4 to 194 (mean 93.5) months.
RESULTS: NA was associated with transitional cell carcinoma in 3 cases. Predisposing factors were assessed in all patients. Previous surgery of the lower urinary tract was detected in 5 cases: ureterocystoneostomy in 2, partial cystectomy in 1, repair of vesicouterine fistula in 1, and multiple urethroplasties in 1. Previous endoscopic treatments were carried out in 2 patients, transurethral resection of the prostate in 1 and repeated transurethral resection of the vesicle in the other. A history of intravesical instillation of bacillus Calmette-Guérin was assessed in 1 case. Patients complained of irritative voiding symptoms in 6 cases and hematuria in 2. Endoscopically, the lesions appeared polypoid and multifocal in 5 patients, and flat and single in 3. The lesions were removed endoscopically, providing relief of symptoms in all cases. Histopathology assessed the diagnosis of nephrogenic adenoma, detecting focal atypic cells in 1 case only. Five patients (63%) relapsed 2-24 months after management. Recurrences were also treated endoscopically.
CONCLUSIONS: Clinical and endoscopic features of bladder NA are not specific, simulating urothelial carcinoma or chronic cystitis. Endoscopic management allows accurate histological diagnosis and provides long-lasting relief of symptoms. NA needs careful and long-term follow-up, because of the high risk of recurrences and the potential neoplastic degeneration of the metaplastic urothelium. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11316978     DOI: 10.1159/000056596

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

1.  Recurrence of childhood nephrogenic adenoma in urinary bladder developed four years after previous surgery despite intravesical sodium hyaluronate therapy.

Authors:  Burak Özçift; Ayper Kaçar; Hüseyin Tuğrul Tiryaki
Journal:  Turk J Urol       Date:  2016-12

Review 2.  Nephrogenic adenoma of the urinary bladder.

Authors:  Konstantinos Zougkas; Marinos Kalafatis; Panagiotis Kalafatis
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

3.  Recurrent nephrogenic adenoma in bladder diverticulum: Case report and literature review.

Authors:  Rafael Boscolo-Berto; Claudio Lamon; Mario Gardi; Roberto Vezzaro; Marina Gardiman
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

4.  [Differential diagnosis of multilocular bladder tumors in young patients: nephrogenic adenoma of the bladder in a 25-year old male cystinuria patient].

Authors:  R Mager; S Hartmann; T Hüsch; M Reiter; M Kurosch; A Haferkamp
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

5.  Nephrogenic adenoma of the urinary bladder.

Authors:  Konstantinos Zougkas; Marinos Kalafatis; Panagiotis Kalafatis
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.266

6.  Nephrogenic adenoma of the bladder: a single institution experience assessing clinical factors.

Authors:  Yooni Yi; Angela Wu; Anne P Cameron
Journal:  Int Braz J Urol       Date:  2018 May-Jun       Impact factor: 1.541

Review 7.  Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Int Sch Res Notices       Date:  2015-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.